We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HUH1V:OMXHEXHuhtamaki Oyj Analysis

Data as of 2026-03-12 - not real-time

€29.06

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The stock is trading around the 20‑day SMA, which sits just above the 50‑day and 200‑day SMAs, indicating a short‑term bullish bias. RSI is in the mid‑30s, suggesting the shares are approaching oversold territory. The MACD line remains below its signal line, generating a bearish histogram and signaling downward momentum. Current market price is well above the DCF fair value, creating a sizeable overvaluation gap. The dividend yield sits near 4 % with a payout ratio around 60 %, offering income appeal. Volume has been stable, and the beta is low, implying limited price swings relative to the market.
Recent financial statements show a decline in net sales year‑over‑year, driven by adverse currency effects, though operating cash flow remains positive. Gross margin and operating margin are modest, and free cash flow comfortably covers the dividend, supporting sustainability. The company’s global footprint across North America, Europe and Asia spreads geographic risk but also exposes it to multiple currencies. With a market‑cap of roughly €3 bn and a solid balance sheet, liquidity risk is low. Given the overvalued pricing and muted growth, the outlook leans toward a cautious stance. Investors should weigh the attractive dividend against the valuation premium and the recent sales weakness.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD divergence
  • RSI indicating oversold conditions
  • Price approaching support level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Attractive dividend yield
  • Stable cash flow generation
  • Valuation gap remains

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Significant overvaluation vs DCF
  • Negative revenue growth
  • Cyclical exposure in consumer packaging

Key Metrics & Analysis

Financial Health

Revenue Growth-7.40%
Profit Margin4.84%
P/E Ratio15.9
ROE9.81%
ROA4.09%
Debt/Equity82.06
P/B Ratio1.7
Op. Cash Flow€477.0M
Free Cash Flow€199.9M

Technical Analysis

TrendBullish
RSI35.2
Support€28.94
Resistance€32.14
MA 20€30.64
MA 50€30.45
MA 200€30.16
MACDBearish
VolumeStable
Fear & Greed Index75.02

Valuation

Fair Value€14.84
Target Price€36.19
Upside/Downside24.54%
GradeOvervalued
TypeValue
Dividend Yield3.89%

Risk Assessment

Beta0.18
Volatility21.10%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.